跳至主要内容
临床试验/JPRN-UMIN000013940
JPRN-UMIN000013940已完成1 期

Allogeneic stem cell transplantation for relapsed/refractory aggressive lymphoma with conditioning regimen consisted of fludarabine, iv busulfan, and melphalan (single center prospective trial) - Allogeneic stem cell transplantation for relapsed/refractory aggressive lymphoma with fludarabine, iv busulfan, and melphalan.

Department of Hematology Toranomon Hospital0 个研究点目标入组 12 人开始时间: 2014年5月13日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Positive for anti-HIV antibody Active double cancer Severe mental conditions Active infectious disease Known hypersensitivity to drugs to be used in the protocol. Not appropriate for enrollment as judged by the investigator.

研究者

发起方
Department of Hematology Toranomon Hospital

相似试验